briakinumab
briakinumab noun: a human monoclonal antibody being developed to treat rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.
Noun
briakinumab (uncountable)
- A human monoclonal antibody being developed to treat rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.
- As another interleukin 12/23 antagonist, briakinumab, was withdrawn from further development in part due to concerns about cardiovascular safety, discussion has also emerged on cardiovascular safety of ustekinumab.2015 December 4, “Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients”, in PLOS ONE, →DOI
Origin of briakinumab
From -kin- (“interleukin”) + -umab (“human monoclonal antibody”).
Questions about briakinumab
- What does briakinumab mean?
- Briakinumab means a human monoclonal antibody being developed to treat rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.
- What part of speech is briakinumab?
- Briakinumab is a noun.
Words near briakinumab in the dictionary
Source and license
Adapted from Wiktionary: briakinumab (page history and authors). Text available under the Creative Commons Attribution-ShareAlike 4.0 license. Word.ws reformatted the entry and added links. Wiktionary data of 2026-09-02.
Last updated:
Cite this entry: “briakinumab.” Word.ws, https://word.ws/briakinumab. Based on Wiktionary, CC BY-SA 4.0.
